Novel stem cell therapy using technology from mRNA COVID-19 vaccines may stimulate natural repair in treatment of chronic and acute liver disease
2023-12-07
(Press-News.org) BOSTON – Mortality related to end stage liver disease is ranked as the 12th most common cause of death in the U.S. Liver transplantation remains the only treatment for end stage liver disease, but there is a critical shortage of organ donors, necessitating a dire need for new forms of treatment.
New research from Boston Medical Center and Boston University Chobanian & Avedisian School of Medicine’s Center for Regenerative Medicine (CReM) found evidence that a novel stem cell treatment, using mRNA technology encapsulated into nanoparticles (LNP) that was successfully used to produce the COVID-19 vaccines, may boost the natural repair mechanism of the liver to regress the diseased tissue caused by either an acute or chronic liver injury. Published in Cell Stem Cell, researchers identified a specific receptor present on the stem cells which can be recognized and activated by the ligand protein called vascular endothelial growth factor A (VEGFA).
“This potential treatment has important clinical implications for people suffering from chronic liver disease, allowing the liver to heal itself, and potentially avoiding the need for many liver transplants,” said corresponding author, Valerie Gouon-Evans, PhD, PharmD, Director of the Boston University Liver Biologist Program, Associate Professor at Boston University Chobanian & Avedisian School of Medicine, and CReM faculty. “It’s our hope that these findings, with further study, will be translated to clinical patient care to alleviate chronic liver disease and the need for transplants as a result of acute or chronic injury.”
The liver is known for its remarkable regenerative ability through proliferation of hepatocytes. But during chronic injury or severe hepatocyte death, proliferation of hepatocytes is exhausted. To overcome this hurdle, researchers studied VEGFA as a therapeutic means to accelerate biliary epithelial cell (BEC)-to-hepatocyte conversion.
Researchers used mice and zebrafish liver disease models. In the zebrafish studies, the liver disease was created by inducing hepatocyte death with genetic and chemical intervention. The experimental group of fish was then exposed to overexpression of VEGFA while the control group was not. Researchers observed a significant increase of newly generated hepatocytes from the BEC-derived stem cells in the presence of VEGFA.
In the mouse study, the acute disease was induced with an overdose of the drug acetaminophen, and the chronic disease was promoted with a diet. The experimental groups were treated with 2 injections of VEGFA mRNA-LNP, while the control groups were injected with neutral mRNA-LNP. Researchers demonstrated that delivery of VEGFA mRNA-LNP in both acutely or chronically injured livers induced robust BEC-to-hepatocyte conversion with a five-fold increase compared to control-treated mice, and importantly full reversion of steatosis and fibrosis in the chronic model.
This treatment activates the stem cells of the liver, a subset of the biliary epithelial cells (BEC) lining up the liver biliary tree, so that they proliferate and generate new healthy hepatocytes, the functional cells of the liver.
Nearly 30% of severe cases of acetaminophen overdose require liver transplantation because the gold standard-of-care NAC currently used in the clinic to neutralize acetaminophen toxic metabolite has a very narrow time frame of efficiency. The data suggest VEGFA mRNA-LNP as an alternative treatment for severe acetaminophen intoxication that would prevent liver failure and, thus, the need for transplantation for the many overdosed patients who come too late to the ER.
This study has critical clinical implications establishing potential novel treatments for liver diseases by exploiting and optimizing the naturally occurring BEC-mediated repair mechanism of the liver to a clinically relevant extent by delivery of VEGFA into the liver using the clinically safe mRNA-LNPs.
###
About Boston Medical Center
Boston Medical Center models a new kind of excellence in healthcare, where innovative and equitable care empowers all patients to thrive. We combine world-class clinicians, cutting-edge treatments, and advanced technology with compassionate, quality care, that extends beyond our walls. As an award-winning health equity leader, our diverse clinicians and staff interrogate racial disparities in care and partner with our community to dismantle systemic inequities. And as a national leader in research and the teaching affiliate for Boston University Chobanian & Avedisian School of Medicine, we’re driving the future of care.
END
ELSE PRESS RELEASES FROM THIS DATE:
2023-12-07
Published in the 2023 Volume 3 issue of Psychoradiology a team of dedicated researchers from The University of Hong Kong and The University of Electronic Science and Technology of China has conclusively identified the right inferior frontal gyrus (rIFG) as a key input and causal regulator within the subcortical response inhibition nodes. This right-lateralized inhibitory control circuit, characterized by its significant intrinsic connectivity, highlights the crucial role of the rIFG in orchestrating top-down cortical-subcortical control, underscoring the intricate dynamics of brain function in response inhibition.
In ...
2023-12-07
Although SARS-CoV-2 is no longer a stranger to the immune system, new virus variants still pose a challenge. The working group led by Professor Dr Florian Klein, Director of the Institute of Virology at the University Hospital Cologne and the Faculty of Medicine, has now published two studies investigating how the antibody response to SARS-CoV-2 changes over time and how the immune system is preparing itself for new variants with clever strategies. The work has been published under the title ‘Enhanced ...
2023-12-07
Sage has launched a tool to empower researchers to discover the real-world impact of their work on policy. Sage Policy Profiles lets researchers easily see specific citations of their work in policy documents and then illustrate and share that work’s impact graphically. The tool is powered by Overton, which hosts an extensive repository of global policy documents, guidelines, think-tank publications, and working papers.
The free-of-charge, browser-based tool shows researchers where their work appears in evidence-based policies, offering insights into how policymakers make use of their research. Sage Policy Profiles presents these results ...
2023-12-07
ITHACA, N.Y. – Cornell University researchers have released a new, open-source platform called Cascade that can run artificial intelligence models in a way that slashes expenses and energy costs while dramatically improving performance.
Cascade is designed for settings like smart traffic intersections, medical diagnostics, equipment servicing using augmented reality, digital agriculture, smart power grids and automatic product inspection during manufacturing – situations where AI models must react within a fraction of a second.
With the rise of AI, many companies are eager to leverage new capabilities but worried about the associated computing ...
2023-12-07
Maternal inflammation risk factors may be associated with dysregulation in children, according to a study funded by the Environmental influences on Child Health Outcomes (ECHO) Program at the National Institutes of Health. “Dysregulation” in this context refers to children’s attention, anxiety and depression, and aggression being measurably different from what is typically expected at their age.
While inflammation is a normal bodily response to injury or infection, ECHO investigators wanted to learn whether factors linked ...
2023-12-07
Around 320,000 new cases of leukaemia, a type of blood cancer that can affect all population groups, are diagnosed every year in Europe. In children, cases of leukaemia make up a third of diagnosed cancers. Chemotherapy is the main treatment for leukaemia. Often, the exact cause cannot be identified and the molecular and cellular mechanisms responsible for leukaemia remain shrouded in mystery. Discovering new detection methods and new treatments to eradicate leukaemia is therefore a major challenge in oncology.
Messenger RNA has been in the news in recent months, in connection with COVID-19 vaccinations. In an article published in Molecular Cell, researchers ...
2023-12-07
ITHACA, N.Y. – A new study of paper wasps suggests social interactions may make animals smarter. The research offers behavioral evidence of an evolutionary link between the ability to recognize individuals and social cooperation.
Furthermore, genomic sequencing revealed that populations of wasps that recognized each other – and cooperated more – showed recent adaptations (positive selection) in areas of the brain associated with cognitive abilities such as learning, memory and vision.
The study focused on two distinct populations of paper wasps (Polistes fuscatus): A southern ...
2023-12-07
Key to fatty liver disease and its consequences for billions of people
The global rise in obesity and diabetes is leading to an epidemic in fatty liver disease affecting 20-30 per cent of the world’s population. Almost a third of people with fatty liver disease go on to develop an advanced form of the disease, known as non-alcoholic steatohepatitis (NASH) that can progress to cirrhosis and end-stage liver disease, or even liver cancer, and is a major risk factor for cardiovascular disease.
Why some people remain relatively healthy with fatty liver disease and some go onto potentially life-threatening illness has been a mystery. Until now.
A study ...
2023-12-07
From the 1950s to the 1970s, a Colombian priest named Padre Gustavo Huertas collected rocks and fossils near a town called Villa de Levya. Two of the specimens he found were small, round rocks patterned with lines that looked like leaves; he classified them as a type of fossil plant. But in a new study, published in the journal Palaeontologia Electronica, researchers re-examined these “plant” fossils and found that they weren’t plants at all: they were the fossilized remains of baby turtles.
“It was truly surprising to find these fossils,” says Héctor Palma-Castro, a paleobotany student at the Universidad Nacional de Colombia.
The plants in question ...
2023-12-07
Pancreatic ductal adenocarcinoma (PDAC), that arises from pancreatic epithelial cells, is the most common form of pancreatic cancer, with a very high mortality rate. This elevated mortality is associated with the unique tumor microenvironment (TME), known for increased resistance to chemotherapy and high metastatic potential. TME is characterized by the presence of a complex stromal structure comprising cancer-associated fibroblasts (CAFs), tumor endothelial cells (TECs), and a variety of immune cells.
CAFs are specific cells, primarily involved in the overall aggressiveness and spread of cancer cells. These cells can further be categorized into several types based on their ...
LAST 30 PRESS RELEASES:
[Press-News.org] Novel stem cell therapy using technology from mRNA COVID-19 vaccines may stimulate natural repair in treatment of chronic and acute liver disease
